These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3276392)

  • 41. Expression of ras oncogene p21 protein in early gastric carcinoma and adjacent gastric epithelia.
    Czerniak B; Herz F; Gorczyca W; Koss LG
    Cancer; 1989 Oct; 64(7):1467-73. PubMed ID: 2550123
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin.
    Motoi N; Sakamoto A; Yamochi T; Horiuchi H; Motoi T; Machinami R
    Pathol Res Pract; 2000; 196(1):1-7. PubMed ID: 10674266
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The variable phenotype and low-risk nature of RAS-positive thyroid nodules.
    Medici M; Kwong N; Angell TE; Marqusee E; Kim MI; Frates MC; Benson CB; Cibas ES; Barletta JA; Krane JF; Ruan DT; Cho NL; Gawande AA; Moore FD; Alexander EK
    BMC Med; 2015 Aug; 13():184. PubMed ID: 26253102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD98 expression is decreased in papillary carcinoma of the thyroid and Hashimoto's thyroiditis.
    Anderson CE; Graham C; Herriot MM; Kamel HM; Salter DM
    Histopathology; 2009 Dec; 55(6):683-6. PubMed ID: 19922591
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues.
    Tiniakos D; Spandidos DA; Kakkanas A; Pintzas A; Pollice L; Tiniakos G
    Anticancer Res; 1989; 9(3):715-21. PubMed ID: 2548435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Immunohistochemical studies of ras oncogene product p21 in human ovarian tumors].
    Yaginuma Y; Yamashita K
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1409-16. PubMed ID: 2685141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of the apical iodide transporter in human thyroid tissues: a comparison study with other iodide transporters.
    Lacroix L; Pourcher T; Magnon C; Bellon N; Talbot M; Intaraphairot T; Caillou B; Schlumberger M; Bidart JM
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1423-8. PubMed ID: 15001644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
    Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
    Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ras oncogene p21 expression in hepatocellular carcinoma.
    Jagirdar J; Nonomura A; Patil J; Thor A; Paronetto F
    J Exp Pathol; 1989; 4(1):37-46. PubMed ID: 2550600
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
    Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
    J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and histopathologic evaluation of the expression of Ha-ras and fes oncogene products in lung cancer.
    Nishio H; Nakamura S; Horai T; Ikegami H; Matsuda M
    Cancer; 1992 Mar; 69(5):1130-6. PubMed ID: 1310887
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Memory T cells of a patient with follicular thyroid carcinoma recognize peptides derived from mutated p21 ras (Gln-->Leu61).
    Gedde-Dahl T; Spurkland A; Eriksen JA; Thorsby E; Gaudernack G
    Int Immunol; 1992 Nov; 4(11):1331-7. PubMed ID: 1282032
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.
    An JH; Song KH; Kim SK; Park KS; Yoo YB; Yang JH; Hwang TS; Kim DL
    Clin Endocrinol (Oxf); 2015 May; 82(5):760-6. PubMed ID: 25109485
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated levels of polyamines and histamine in adenocarcinomas of the thyroid.
    Matsuzaki S; Suzuki M; Hamana K; Itoh K
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1038-41. PubMed ID: 263733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. BRAF and RAS Mutational Status in Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Invasive Subtype of Encapsulated Follicular Variant of Papillary Thyroid Carcinoma in Korea.
    Kim M; Jeon MJ; Oh HS; Park S; Kim TY; Shong YK; Kim WB; Kim K; Kim WG; Song DE
    Thyroid; 2018 Apr; 28(4):504-510. PubMed ID: 29439609
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunolocalization of ras oncogene p21 in human liver diseases.
    Radosevich JA; Gould KA; Koukoulis GK; Haines GK; Rosen ST; Lee I; Gould VE
    Ultrastruct Pathol; 1993; 17(1):1-8. PubMed ID: 8381245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunohistochemical detection of ras 21 in oral squamous cell carcinomas.
    Satoh M; Hatakeyama S; Sashima M; Suzuki A
    Oral Surg Oral Med Oral Pathol; 1992 Oct; 74(4):469-72. PubMed ID: 1408023
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of HLA-DR antigens in paraffin-embedded thyroid epithelial cells with a monoclonal antibody.
    Lloyd RV; Johnson TL; Blaivas M; Sisson JC; Wilson BS
    Am J Pathol; 1985 Jul; 120(1):106-11. PubMed ID: 3893150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flow cytometric DNA measurement in benign and malignant human thyroid tissues.
    Mizukami Y; Nonomura A; Michigishi T; Kosaka T; Noguchi M; Nakamura S; Hashimoto T
    Anticancer Res; 1992; 12(6B):2213-7. PubMed ID: 1295468
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.
    Miyamoto H; Harada M; Isobe H; Akita HD; Haneda H; Yamaguchi E; Kuzumaki N; Kawakami Y
    Cancer Res; 1991 Dec; 51(23 Pt 1):6346-50. PubMed ID: 1657384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.